| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $97.0M | — | +57.9% |
| Cost of Revenue | $71.2M | — | +35.9% |
| Gross Profit | $25.8M | — | +185.5% |
| R&D Expense | $12.6M | — | +1447.6% |
| SG&A Expense | $82.9M | — | +342.2% |
| Operating Income | -$69.7M | — | -386.8% |
| Pre-tax Income | -$75.9M | — | -2323.7% |
| Income Tax | $641K | — | +452.2% |
| Net Income | -$76.5M | — | -2495.0% |
| EPS (Basic) | -$0.40 | — | -344.4% |
| EPS (Diluted) | -$0.40 | — | -344.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $144.5M | +53.0% | +166.5% |
| Accounts Receivable | $24.3M | -34.7% | +59.7% |
| Inventory | $69.3M | +24.2% | +3063.8% |
| Current Assets | $320.7M | +26.9% | +125.6% |
| Total Assets | $1.51B | +4.3% | +381.1% |
| Current Liabilities | $183.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.7M | — | +85.2% |
| Capital Expenditures | $4.8M | — | +165.6% |
| Investing Cash Flow | -$6.0M | — | -48.9% |
| Financing Cash Flow | $63.1M | — | +16.4% |
| Free Cash Flow | -$11.4M | — | +75.6% |
| +54.5% |
| Long-term Debt | $88.2M | +3.5% | -16.1% |
| Total Liabilities | $346.6M | +11.0% | +40.1% |
| Stockholders' Equity | $1.09B | +2.6% | +1697.8% |